Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway
Jennifer L. Gommerman, … , Pauline Martin, Jeffrey L. Browning
Jennifer L. Gommerman, … , Pauline Martin, Jeffrey L. Browning
Published November 1, 2002
Citation Information: J Clin Invest. 2002;110(9):1359-1369. https://doi.org/10.1172/JCI15975.
View: Text | PDF
Article Aging

Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway

  • Text
  • PDF
Abstract

Research Article

Authors

Jennifer L. Gommerman, Fabienne Mackay, Elina Donskoy, Werner Meier, Pauline Martin, Jeffrey L. Browning

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
B cell and T cell areas are mostly unaltered by LTβR-Ig treatment, but C...
B cell and T cell areas are mostly unaltered by LTβR-Ig treatment, but CD21 staining is diminished. Representative spleens from untreated (a, d, g), treated (8 mg/kg LTβR-Ig) (b, e, h), and recovery animals (8 mg/kg treatment followed by 3-month recovery) (c, f, i) were stained with anti-CD20 Ab’s (blue). Sections were costained with anti-CD3 Ab’s (brown) (a–c), or the FDC-specific clone CNA.42 (brown) (d–f), or the CD21-specific R42/3 clone (dark brown) (g–i). Spleens were photographed at ×100. T, T cell zone; T/B interface, T cell/B cell interface.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts